Abstract
The heart is the first organ to form during development in vertebrates, and many organs start to develop adjacent to the cardiovascular system. Endothelial cells (ECs) form the inner cell lining of blood vessels and represent the major cell type that interacts with developing organs including the pancreas. ECs receive signals from the developing pancreas to grow and, at the same time, release signals to determine cell-fate specification, morphogenesis and function of the pancreas. In addition to promoting survival of pancreatic islets, in this review, we discuss the role of the vascular niche and angiogenic factors, particularly VEGFA, during pancreatic beta cell development, regeneration and pathophysiological progression of diabetes. Nevertheless, unraveling the molecular signals involved in pancreatic beta cell development and regeneration may shed light into novel drug development to treat diabetes.
Keywords: Angiogenesis, autoimmunity, diabetes, pancreatic beta cells, regeneration.
Current Stem Cell Research & Therapy
Title:VEGF-A: The Inductive Angiogenic Factor for Development, Regeneration and Function of Pancreatic Beta Cells
Volume: 9 Issue: 5
Author(s): Kathy O. Lui
Affiliation:
Keywords: Angiogenesis, autoimmunity, diabetes, pancreatic beta cells, regeneration.
Abstract: The heart is the first organ to form during development in vertebrates, and many organs start to develop adjacent to the cardiovascular system. Endothelial cells (ECs) form the inner cell lining of blood vessels and represent the major cell type that interacts with developing organs including the pancreas. ECs receive signals from the developing pancreas to grow and, at the same time, release signals to determine cell-fate specification, morphogenesis and function of the pancreas. In addition to promoting survival of pancreatic islets, in this review, we discuss the role of the vascular niche and angiogenic factors, particularly VEGFA, during pancreatic beta cell development, regeneration and pathophysiological progression of diabetes. Nevertheless, unraveling the molecular signals involved in pancreatic beta cell development and regeneration may shed light into novel drug development to treat diabetes.
Export Options
About this article
Cite this article as:
Lui O. Kathy, VEGF-A: The Inductive Angiogenic Factor for Development, Regeneration and Function of Pancreatic Beta Cells, Current Stem Cell Research & Therapy 2014; 9 (5) . https://dx.doi.org/10.2174/1574888X09666140710100603
DOI https://dx.doi.org/10.2174/1574888X09666140710100603 |
Print ISSN 1574-888X |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-3946 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Targeting Redox Signaling in the Vascular Wall: From Basic Science to Clinical Practice
Current Pharmaceutical Design Use of BNP and CRP as Biomarkers in Assessing Cardiovascular Disease:Diagnosis Versus Risk
Current Vascular Pharmacology Inpatient Care of the HIV Infected Patient in the Highly Active Antiretroviral Therapy (HAART) Era
Current HIV Research Aldose Reductase Inhibitors and Nanodelivery of Diabetic Therapeutics
Mini-Reviews in Medicinal Chemistry Staurosporine Analogues from Microbial and Synthetic Sources and Their Biological Activities
Current Medicinal Chemistry MicroRNAs in Peripheral Artery Disease
Current Topics in Medicinal Chemistry Fatty Acids: Friends or Foe? Relation Between Dietary Fat and Insulin Sensitivity
Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued) Gender Disparities on Access to Care and Coronary Disease Management
Current Pharmaceutical Design Pharmacogenomics of Open-Angle Glaucoma
Current Pharmacogenomics and Personalized Medicine An Overview of Nanoformulated Nutraceuticals and their Therapeutic Approaches
Current Nutrition & Food Science The Adipocyte as a Novel TSH Target
Mini-Reviews in Medicinal Chemistry Myocardial Infarction with Non Obstructive Coronary Atherosclerosis: A Case Report
New Emirates Medical Journal COVID-19, Angiotensin-Converting Enzyme 2 and Renin-Angiotensin System Inhibition: Implications for Practice
Current Hypertension Reviews Pathogenesis in Childhood Idiopathic Nephrotic Syndrome: An Update of Patchwork
Current Pediatric Reviews Determination of Manidipine in Human Plasma by UPLC–MS/MS and its Application to a Bioequivalence Study
Current Pharmaceutical Analysis subject Index To Volume 2
Current Drug Targets - Immune, Endocrine & Metabolic Disorders Intestinal Targeting of Drugs: Rational Design Approaches and Challenges
Current Topics in Medicinal Chemistry Physical Activity and Diabetic Cardiomyopathy: Myocardial Adaptation Depending on Exercise Load
Current Diabetes Reviews Editorial: Look for Changes in 2016
Current Molecular Medicine High-dose Cholecalciferol Supplementation Reducing Morning Blood Pressure in Normotensive DM1 Patients
Current Diabetes Reviews